TCL Archive Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival March 28, 2014
TCL Archive Niederhuber Says Resignation “Pro Forma,” Hopes To Stay As Director Or Lab Chief. December 19, 2008
TCL Archive Changes In Clinical Trials Mechanism Inevitable, But NCI Says It will Heed Critics Of Proposals April 18, 1986